Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community. The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care. Read More
Medical professional network Doximity (NYSE:DOCS) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 9.8% year on year to $185.1 million. On the other hand, next quarter’s revenue guidance of $143.5 million was less impressive, coming in 5.2% below analysts’ estimates. Its non-GAAP profit of $0.46 per share was 2.9% above analysts’ consensus estimates.
A number of stocks fell in the afternoon session after the "AI replacement" narrative reached a fever pitch following the release of new models from Anthropic and OpenAI.
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Conferencing Platform in the 2026 Best in KLAS Report. This is the fifth consecutive year that Doximity has earned the top spot, underscoring its position as a trusted, long-term partner for physicians and health systems.
Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025.
A number of stocks fell in the afternoon session after fears of disruption from artificial intelligence spooked investors, leading to a broad-based sell-off. The market witnessed a "basket-style reaction," a term for when investors reduce exposure to an entire segment without differentiating between individual company business models. The negative sentiment was widespread, pulling down all of the Magnificent Seven stocks and sending the S&P 500 Information Technology Sector down nearly 3%.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results.
What a brutal six months it’s been for Doximity. The stock has dropped 35% and now trades at $40.32, rattling many shareholders. This might have investors contemplating their next move.
A number of stocks fell in the afternoon session after tech stocks pulled back as reports surfaced that Chinese customs authorities blocked Nvidia's H200 AI chips, effectively halting their entry despite recent U.S. export approvals.
The digital health landscape faced a sobering milestone this week as shares of Doximity, Inc. (NYSE: DOCS), the leading professional network for physicians, plummeted to a new 52-week low. On January 12, 2026, the stock touched $43.21, marking a dramatic retreat from its February 2025 peak of $85.21.
A number of stocks fell in the morning session after a broader market rotation out of the technology sector led to profit-taking following a recent rally.
Looking back on vertical software stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Doximity (NYSE:DOCS) and its peers.
A number of stocks jumped in the afternoon session after investors wagered geopolitical tension would be contained following the U.S. military's operation in Venezuela, with the Dow hitting a fresh record.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
As the final trading days of 2025 wind down, the global financial landscape is witnessing a structural shift that many analysts are calling the "Great Rebalancing." For much of the last three years, the market’s fate was tied almost exclusively to a handful of tech titans known as the
Shares of medical professional network Doximity (NYSE:DOCS) jumped 3.3% in the afternoon session after the stock's positive momentum continued as a Bank of America analyst reiterated a Buy rating and an $82 price target on the stock.
